fingolimod hydrochloride has been researched along with Carcinoma, Merkel Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvi, A; Carandini, T; De Riz, M; Galimberti, D; Ghezzi, L; Lecchi, E; Maurichi, A; Pellegrinelli, A; Pietroboni, A; Scarioni, M; Scarpini, E | 1 |
| Billings, SD; Cohen, JA; Hudgens, CW; Ko, JS; Mahajan, KR; Tetzlaff, MT | 1 |
| Barnett, MH; Beadnall, HN; Gill, AJ; Riminton, S | 1 |
3 other study(ies) available for fingolimod hydrochloride and Carcinoma, Merkel Cell
| Article | Year |
|---|---|
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod.
Topics: Carcinoma, Merkel Cell; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphopenia; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Skin Neoplasms | 2017 |
Merkel cell carcinoma with fingolimod treatment for multiple sclerosis: A case report.
Topics: Carcinoma, Merkel Cell; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Merkel cell polyomavirus; Middle Aged; Multiple Sclerosis; Polyomavirus Infections; Skin Neoplasms | 2017 |
Virus-related Merkel cell carcinoma complicating fingolimod treatment for multiple sclerosis.
Topics: Carcinoma, Merkel Cell; Fingolimod Hydrochloride; Humans; Immunocompromised Host; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Skin Neoplasms | 2016 |